GlassScriptPhysician profile
Chauncey C Stokes
NPI 1437141173
$2,026.28
in general payments reported to CMS, 2019-2025
27 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $255 · 2021: $389 · 2022: $316 · 2023: $263 · 2024: $200 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $680.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $378.27 | 2019-2022 | |
| Intuitive Surgical, INC. | $190.00 | 2019-2022 | |
| Therapeuticsmd, INC. | $151.65 | 2019-2021 | |
| Astellas Pharma US INC | $128.16 | 2023-2025 | Veozah |
| Renovia INC | $125.57 | 2021 | |
| Mayne Pharma Commercial LLC | $108.35 | 2022-2025 | |
| Coopersurgical, INC. | $85.06 | 2022-2024 | Paragard T 380a, Paragard T 380a |
| Dysis Medical, INC. | $82.07 | 2020-2023 | Dysis View, Dysis V3 Digital Coploscope, Dysis Ultra 2.0 |
| Organon LLC | $81.77 | 2024-2025 | Nexplanon |
| Exeltis, USA INC. | $79.21 | 2020-2025 | Slynd |
| Sumitomo Pharma America, INC. | $77.50 | 2023-2024 | Myfembree |
| Aspira Women'S Health INC | $66.23 | 2022-2023 | Ova1 |
| Bayer Healthcare Pharmaceuticals INC. | $59.12 | 2022-2025 | |
| Roche Diagnostics Corporation | $58.18 | 2019-2021 | |
| Avion Pharmaceuticals | $56.86 | 2019-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $47.79 | 2021-2022 | |
| Daiichi Sankyo INC. | $38.21 | 2023 | Injectafer |
| Vertical Pharmaceuticals, LLC | $37.55 | 2019 | |
| Ethicon US, LLC | $27.53 | 2021 | |
| Dexcom, INC. | $23.16 | 2025 | Dexcom G6 Transmitter |
| Meditrina | $22.58 | 2025 | |
| Exact Sciences Corporation | $20.46 | 2023 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $17.88 | 2021 | |
| Mylan Pharmaceuticals INC. | $17.80 | 2020 | |
| Amag Pharmaceuticals, INC. | $16.20 | 2020 | |
| Sage Therapeutics, LLC | $15.24 | 2025 | Zurzuvae |
| Optumhealth Care Solutions, LLC | $13.88 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chauncey Stokes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.